SIE, SIES, GITMO revised guidelines for the management offollicular lymphoma
                                                Am. j. hematol; 90 (1), 2005                                            
                                        
                                                                                    
                                                By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...                                            
                                        
                                                                                    
                                                
                                                Anticorps monoclonaux, Anticorps, Anticorps monoclonaux d'origine murine/usage thérapeutique, Antinéoplasiques, Calendrier d'administration des médicaments, Transplantation de cellules souches hématopoïétiques, Lymphome folliculaire/anatomopathologie, Lymphomes/thérapie, Stadification tumorale, Rituximab, Facteurs temps                                            
                                        
                                                                                    
                                                                             
                        